Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +4 more
  • AB248
  • Pembrolizumab
  • Lafayette, Indiana
  • +2 more
Jan 25, 2023

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Solid Tumor Trial in Worldwide (Durvalumab)

Active, not recruiting
  • Solid Tumor
  • Fullerton, California
  • +115 more
Jan 12, 2023

Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Boston, Massachusetts
  • +12 more
Jan 10, 2023

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

Recruiting
  • Solid Tumor
  • +7 more
  • Duarte, California
  • +11 more
Jan 6, 2023

Solid Tumor Trial in United States (ASP3082)

Recruiting
  • Solid Tumor
  • Santa Monica, California
  • +10 more
Jan 6, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Solid Tumor Trial in Worldwide (BDTX-189)

Terminated
  • Solid Tumor
  • Scottsdale, Arizona
  • +37 more
Oct 13, 2022

Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • Birmingham, Alabama
  • +20 more
Aug 22, 2022

Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

Suspended
  • Solid Tumor
  • NeoTCR-P1 adoptive cell therapy
  • +2 more
  • Duarte, California
  • +8 more
Aug 16, 2022

Solid Tumor Trial in Australia, United States (BGB-B167, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • Duarte, California
  • +6 more
Aug 8, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Solid Tumor Trial in United States (AO-176, AO-176 + Paclitaxel, AO-176 + Pembrolizumab)

Active, not recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Aug 3, 2022

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Solid Tumor Trial in United States (CI-8993)

Recruiting
  • Solid Tumor
  • Lebanon, New Hampshire
  • +4 more
Jul 19, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

Active, not recruiting
  • Bladder Cancer
  • +3 more
  • IPI-549 (eganelisib)
  • +2 more
  • Fort Wayne, Indiana
  • +28 more
Apr 1, 2022